Thank you
This live web event has ended. Thank you for attending.
This live web event has ended. Thank you for attending.
Neil is the
Founder and Director of Spooner Bioanalytical Solutions, a consultancy based in
Hertford, UK. In this role, Neil helps
companies to integrate microsampling of biological fluids into pre-clinical,
clinical and bioanalytical workflows. He
also works with innovator companies to help them develop novel microsampling
and microanalytical technologies and introduce them to the market. Neil is also a Senior Visiting Research
Fellow at the School of Life and Medical Sciences, University of Hertfordshire
(Hertfordshire, UK), the Senior Editor of Bioanalysis Journal and the
Deputy-Chair and Secretary of the Reid Bioanalytical Forum. He has published
extensively, with over 60 peer reviewed manuscripts and more than 40 podium
presentations at International Conferences and Symposia.
Neil has extensive experience in the
quantitative bioanalysis of drugs, metabolites and biomarkers in the
pharmaceutical industry and contract research organisations in the UK and
USA. In over 20 years of industrial
practice at GlaxoSmithKline, he has led groups operating in the discovery and
regulated arenas of clinical and pre-clinical quantitative bioanalysis and
metabolite identification. Neil has
extensive experience of successfully leading inter departmental and cross functional
initiatives, including implementation of new technologies and workflows (such
as microsampling), outsourcing quantitative bioanalysis, development and
implementation of automation approaches and design of new scientific
facilities.
Prajakti Kothare
(Ph.D.) is Executive Director, Quantitative Pharmacology and Pharmacometrics within
Pharmacokinetics, Pharmacodynamics and Drug Metabolism at Merck. As part of this role she provides strategic,
personnel and portfolio oversight for translational and quantitative aspects of
Infectious Diseases, Cardiometabolic and Opthalmics programs from discovery
through life-cycle management. Prajakti
is an experienced pharmaceutical
research leader with a proven track record of portfolio and regulatory impact across
multiple therapeutic areas and across modalities.
Since joining Merck in 2011, Prajakti
has assumed leadership positions of increasing responsibility. Prajakti has played a critical leadership role
in building quantitative translational sciences at Merck. Prajakti has been instrumental in driving efforts
aimed at modernizing clinical trials such as the application of dried blood spots, digital
health and home-sampling in clinical trials resulting in faster, efficient
decisions. From
2001-2011, while at Eli Lilly and Company (Global Pharmacokinetics and
Pharmacodynamics), she was significantly involved in the development and
registration of multiple drugs. Prajakti
received a Bachelor’s degree in Pharmaceutical Sciences from the University of
Bombay, India and a Ph.D. in Pharmaceutics (with a specialization in PKPD) from
the University of Minnesota.